Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
‘Where we are today in biology AI is similar to GPT in 2020’: An interview with the CEO (@kbeguir) of Africa’s biggest AI startup (@instadeepai). https://t.co/bw2h9whJPu
Hey everyone! Today, I want to introduce you to WhatWide lab A fascinating development in the world of artificial intelligence If you're curious about how AI is evolving and impacting various industries then you have to check this out!!!!👇👇 https://t.co/gypSN33TK0
BioNTech and InstaDeep focus on scalable AI systems for advanced biological challenges. “By scaling our models, such as moving from 150M to 15B parameters, training losses decrease, leading to better performance on downstream biological tasks" https://t.co/K7hr7Qgbvu
In a recent interview, the CEO of Instadeep, Africa's largest AI startup, compared the current state of biology AI to the early days of GPT technology in 2020. This discussion follows the acquisition of Instadeep by German biotech firm BioNTech for over $550 million in January 2023. The collaboration aims to leverage scalable AI systems to address complex biological challenges, with a focus on enhancing vaccine and therapeutic development. BioNTech and Instadeep are working on advancing their AI models, increasing parameters from 150 million to 15 billion, which is expected to improve performance on various biological tasks.
